|
Shestakova I.V., Popovich L.D., Potapchik E.G., Blokhina N.P.
Possible socioeconomic effect of the introduction of innovative treatment technology for chronic hepatitis C in Russia
|
№2 / 2016
|
|
Sagalova O.I.
Interferon-free antiviral therapy for chronic hepatitis C
|
№2 / 2015
|
|
Lobzin Yu.V., Kuznetsov N.I., Romanova E.S.
Recombinant Il-1β in the combination therapy of chronic hepatitis C
|
№4 / 2014
|
|
Ignatova T.M.
Use of telaprevir in real clinical practice
|
№3 / 2014
|
|
Reizis A.R., Khokhlova O.N., Serebrovskaya L.V.
A new prognostic test for the efficiency of antiviral therapy for chronic hepatisis C in adults and children as a principle of personified medicine
|
№2 / 2014
|
|
Ivanova M.R., Marzhokhova M.Yu.
Analysis of the efficiency of antiviral therapy for chronic hepatitis C
|
№4 / 2013
|
|
Syutkin V.E., Salienko A.A.
Hepatitis D. The present state of the problem and unsolved problems
|
№4 / 2013
|
|
Konstantinov D.Yu., Konstantinova E.A., Popova L.L., Strebkova E.A., Suzdaltsev A.A.
New approaches to optimizing antiviral therapy in patients with chronic hepatitis C and low baseline leukocyte content
|
№3 / 2013
|
|
Kaliaskarova K.S., Tuganbekova S.K., Kuzembaeva K.U., Konysbekova A.A., Malova E.S., Glazkova E.Ya., Balmasova I.P., Rybkina A.A., Bunkova E.B., Morozov V.G.
Genotypic profile and dynamics of viral load in patients with chronic hepatitis C during standard antiviral therapy in the representatives of Kazakh and Slavic populations in the Republic of Kazakhstan
|
№3 / 2013
|
|
Lityaeva L.A., Kovaleva O.V., Yakubovich I.S.
Clinical and epidemiological features of enterovirus meningitides in children in the Orenburg Region
|
№2 / 2013
|
|
Znoiko O.O., Dudina K.R., Safiullina N.Kh., Karandashova I.V., Chulanov V.P.
Changes in the degree of hepatic fibrosis due to three-year entecavir therapy in a patient with chronic hepatitis B with an outcome to hepatic cirrhosis
|
№6 / 2012
|
Русский
